ennov Press Releases

Published on May 26, 2025 - 14:33 GMT

Ennov schließt ein eCTD 4.0-Einreichung bei EMA erfolgreich ab und verschafft Kunden damit einen Vorsprung

Ennov hat als einer von vier Anbietern erfolgreich eine eCTD 4.0-Testeinreichung bei der EMA abgeschlossen und verschafft Kunden so einen klaren Vorsprung. PARIS, FRANCE, May 26, 2025 /⁨EINPresswire.com⁩/ -- Ennov, ein globaler Anbieter einer einheitlichen regulatorischen Plattform für Biowissenschaften, hat einen eCTD 4.0-Testeinreichung bei der Europäischen Arzneimittelagentur (EMA) erfolgreich abgeschlossen. Als einer von nur vier Anbietern, die diesen Meilenstein erreichten, wurde die Einreichung von …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 26, 2025 - 14:16 GMT

Ennov réussit une soumission eCTD 4.0 à l'EMA, donnant à ses clients une longueur d'avance

Ennov parmi les premiers fournisseurs à réussir une soumission eCTD 4.0 à l’EMA, prouve sa pleine compatibilité et offre à ses clients une longueur d'avance. PARIS, FRANCE, May 26, 2025 /⁨EINPresswire.com⁩/ -- Ennov, fournisseur mondial d'une plateforme réglementaire unifiée pour les sciences de la vie, a réalisé avec succès une soumission de test eCTD 4.0 auprès de l'Agence européenne des médicaments (EMA). En tant que l'un des quatre fournisseurs à atteindre cette étape, la soumission d…

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on May 26, 2025 - 13:51 GMT

Ennov Successfully Completes eCTD 4.0 Submission with EMA—Giving Customers a Head Start

Successfully completing an EMA eCTD 4.0 test submission, Ennov gives customers early readiness, lower risk, and smoother compliance. PARIS, FRANCE, May 26, 2025 /⁨EINPresswire.com⁩/ -- Ennov, a global provider of unified regulatory platform for life sciences, has successfully completed an eCTD 4.0 test submission to the European Medicines Agency (EMA). One of only four vendors to reach this milestone, Ennov’s submission was accepted, loaded into the EMA’s system, and reviewed without issue: proving full …

Distribution channels: Chemical Industry, Healthcare & Pharmaceuticals Industry ...
Published on June 4, 2024 - 11:48 GMT

Ennov acquires Calyx's Enterprise Technology Division & Creates the Premier Global Compliance Platform for Life Sciences

Ennov expands its Life Sciences compliance platform with the acquisition of Calyx’s Enterprise Tech, enhancing regulatory and clinical study solutions worldwide PARIS, FRANCE, June 4, 2024 /⁨EINPresswire.com⁩/ -- Ennov, the leading unified compliance platform provider for Life Sciences, has announced the acquisition of the assets of Calyx’s Enterprise Technology division, a renowned provider of eClinical and eRegulatory solutions. This strategic acquisition, completed on June 1, 2024, positions Ennov as …

Distribution channels: Beauty & Hair Care, Chemical Industry ...
Published on February 8, 2024 - 09:42 GMT

Ennov acquires Calyx's Enterprise Technology Division & consolidates its unified Life Sciences compliance cloud platform

The acquisition of Calyx's Enterprise Technology by Ennov marks a significant leap in creating the ultimate cloud-based compliance platform for Life Sciences. PARIS, FRANCE, February 8, 2024 /⁨EINPresswire.com⁩/ -- Ennov, the provider of the only unified compliance platform for Life Sciences – a highly configurable software architecture that provides a consistent user experience and eliminates data silos – is pleased to announce the strategic acquisition of the 'Enterprise Technology' division …

Distribution channels: Beauty & Hair Care, Chemical Industry ...
Published on February 6, 2024 - 16:03 GMT

Ennov Acquires DocShifter, the Ultimate Document Conversion Software for Regulated Enterprises

Ennov's acquisition of DocShifter propels Ennov's life sciences regulatory document management platform to the forefront of any format transformation. PARIS, FRANCE, February 6, 2024 /⁨EINPresswire.com⁩/ -- Ennov, provider of the only cloud-based unified compliance platform for life sciences - a highly configurable software architecture that delivers a consistent user experience and eliminates data silos - is proud to announce today the acquisition of DocShifter, a trusted global leader in document …

Distribution channels: Beauty & Hair Care, Chemical Industry ...
Published on May 25, 2023 - 14:00 GMT

Ennov Acquires RIM Solution Provider Samarind

Samarind Strengthens Ennov’s global position in the RIM for Medical Devices and its presence in the UK market PARIS, FRANCE, May 25, 2023 /⁨EINPresswire.com⁩/ -- Ennov, a leading provider of regulated content and data management software for the Life Sciences industry, is happy to announce today that it has acquired UK-based Samarind from its parent company Instem. This acquisition will further strengthen Ennov’s position in the Regulatory Information Management (RIM) software market, especially in the …

Distribution channels: Beauty & Hair Care, Chemical Industry ...
Published on April 21, 2023 - 12:00 GMT

With 30% growth in 2022, Ennov confirms the relevance of its unified platform for life sciences

Ennov experienced robust consolidated revenue growth in 2022 due to the success of its unified platform for life sciences, especially internationally. PARIS, ILE-DE-FRANCE, FRANCE, April 21, 2023 /⁨EINPresswire.com⁩/ -- Ennov's consolidated revenues in 2022 amounted to €33.4M ($36.5M), up 30% compared to 2021. Ennov has vigorously developed its international sales for the last four years, especially in North America and Europe. The company raised its profile by deploying global solutions for …

Distribution channels: Chemical Industry, Food & Beverage Industry ...
Published on March 29, 2023 - 10:31 GMT

Avec 30% de croissance en 2022, Ennov confirme la pertinence de sa plateforme unifiée pour les sciences de la vie

Ennov a connu une forte croissance de son CA consolidé sur 2022, grâce au succès de sa plateforme unifiée pour les sciences de la vie à l’international. PARIS, ÎLE-DE-FRANCE, FRANCE, March 29, 2023 /⁨EINPresswire.com⁩/ -- Le chiffre d’affaires consolidé d’Ennov en 2022 s’est élevé à 33.4M€, en croissance de 30% par rapport à 2021. Depuis 4 ans, Ennov a fortement développé ses ventes à l’international, en particulier en Amérique du Nord et en Europe. L’entreprise a également changé de dimension en …

Distribution channels: Beauty & Hair Care, Chemical Industry ...

Contact

Laure Bros
Ennov
+33140388138

email us here

Share This Newsroom

Facebook Twitter LinkedIn

Company/Organization

Ennov
149 avenue de France
Paris, 75013
France
+33 6 98 32 35 55
Visit Website

LinkedIn X

About

For more than 20 years, Ennov has been developing innovative, powerful, and easy-to-use software for document and process management. Ennov solutions are built on our Unified Compliance Platform which is designed specifically for the management of regulated content and processes. The Ennov platform is the technological foundation of our Regulatory (EDMS, Dossier Publishing, RIM, IDMP), Quality (EDMS, QMS), and Clinical (eTMF and CTMS) solutions.

https://en.ennov.com/about/

The Newsroom of Ennov